MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C ε (PKCε)

Journal of Biological Chemistry

Volumn 288, Issue 12, 2013, Pages 8750-8761

  Körner, Cindy ^a   Keklikoglou, Ioanna ^a   Bender, Christian ^a   Wörner, Angelika ^a   Münstermann, Ewald ^a   Wiemann, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-APOPTOTIC FACTOR; BREAST CANCER CELLS; CELLULAR PHENOTYPES; FUNCTIONAL RELEVANCE; INVERSE CORRELATION; PROTEIN KINASE C; STRESS RESPONSE; TRIPLE-NEGATIVE BREAST CANCERS;

CELL PROLIFERATION; DIAGNOSIS; DISEASES; ENZYMES; GENE EXPRESSION; IONIZING RADIATION; PROTEINS; RNA;

CELL DEATH;

DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 31; PROTEIN BCL 2; PROTEIN KINASE C EPSILON; STAUROSPORINE;

APOPTOSIS; ARTICLE; BCL2 GENE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER PROGNOSIS; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IONIZING RADIATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PRKCE GENE; RADIOSENSITIVITY; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; APOPTOSIS; BASE SEQUENCE; BREAST NEOPLASMS; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; MCF-7 CELLS; MICRORNAS; NF-KAPPA B; PROTEIN KINASE C-EPSILON; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; STAUROSPORINE;

EID: 84875448088     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.414128     Document Type: Article

References (39)

1. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Cancer J. Clin. 55, 74-108
2. Malhotra, G. K., Zhao, X., Band, H., and Band, V. (2010) Histological, molecular and functional subtypes of breast cancers. Cancer Biol. Ther. 10, 955-960
3. Toft, D. J., and Cryns, V. L. (2011) Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. Mol. Endocrinol. 25, 199-211
4. Garg, A. K., Hortobagyi, G. N., Aggarwal, B. B., Sahin, A. A., and Buchholz, T. A. (2003) Nuclear factor-B as a predictor of treatment response in breast cancer. Curr. Opin. Oncol. 15, 405-411
5. Perego, P., Corna, E., De Cesare, M., Gatti, L., Polizzi, D., Pratesi, G., Supino, R., and Zunino, F. (2001) Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines. Curr. Med. Chem. 8, 31-37
6. Catz, S. D., and Johnson, J. L. (2001) Transcriptional regulation of bcl-2 by nuclear factor -B and its significance in prostate cancer. Oncogene 20, 7342-7351
7. Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S., Jr. (1999) NF-B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785-5799
8. Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., and Iglehart, J. D. (2004) NF-B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 101, 10137-10142
9. Biswas, D. K., Martin, K. J., McAlister, C., Cruz, A. P., Graner, E., Dai, S. C., and Pardee, A. B. (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-B activation. Cancer Res. 63, 290-295 (Pubitemid 36152482)
10. Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., and Wirth, T. (2004) NF-B is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114, 569-581
11. Wang, X., and El Naqa, I. M. (2008) Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332 (Pubitemid 351189007)
12. Esquela-Kerscher, A., and Slack, F. J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269
13. Keklikoglou, I., Koerner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Guckel, B., Fehm, T., Schneeweiss, A., Sahin, O., Wiemann, S., and Tschulena, U. (2012) MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-B and TGF- signaling pathways. Oncogene 31, 4150-4163
14. Uhlmann, S., Zhang, J. D., Schwäger, A., Mannsperger, H., Riazalhosseini, Y., Burmester, S., Ward, A., Korf, U., Wiemann, S., and Sahin, O. (2010) miR-200bc/429 cluster targets PLC-1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29, 4297-4306
15. Schramedei, K., Mörbt, N., Pfeifer, G., Läuter, J., Rosolowski, M., Tomm, J. M., von Bergen, M., Horn, F., and Brocke-Heidrich, K. (2011) MicroRNA- 21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 30, 2975-2985
16. Zhu, S., Si, M. L., Wu, H., and Mo, Y. Y. (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282, 14328-14336 (Pubitemid 47100416)
17. Creighton, C. J., Fountain, M. D., Yu, Z., Nagaraja, A. K., Zhu, H., Khan, M., Olokpa, E., Zariff, A., Gunaratne, P. H., Matzuk, M. M., and Anderson, M. L. (2010) Molecular profiling uncovers a p53-associated role for microRNA- 31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70, 1906-1915
18. Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., and Weinberg, R. A. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046
19. Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato-Otsubo, A., Muto, S., Utsunomiya, A., Yamaguchi, K., Uchimaru, K., Ogawa, S., and Watanabe, T. (2012) Polycombmediated loss of miR-31 activates NIK-dependent NF-B pathway in adult T cell leukemia and other cancers. Cancer Cell 21, 121-135
20. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F., and Weinberg, R. A. (2010) Concurrent suppression of integrin -5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. Cancer Res. 70, 5147-5154
21. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F., and Weinberg, R. A. (2011) Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 25, 646-659
22. Shankar, E., Krishnamurthy, S., Paranandi, R., and Basu, A. (2010) PKCepsilon induces Bcl-2 by activating CREB. International journal of oncology 36, 883-888
23. Castro, F., Dirks, W. G., Fähnrich, S., Hotz-Wagenblatt, A., Pawlita, M., and Schmitt, M. (2013) High-throughput SNP-based authentication of human cell lines. Int. J. Cancer 132, 308-314
24. Wang, Y., Xiang, G. S., Kourouma, F., and Umar, S. (2006) Citrobacter rodentium-induced NF-B activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylation. Br. J. Pharmacol. 148, 814-824
25. Malinin, N. L., Boldin, M. P., Kovalenko, A. V., and Wallach, D. (1997) MAP3K-related kinase involved in NF-B induction by TNF, CD95, and IL-1. Nature 385, 540-544
26. Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., and Lacal, J. C. (1997) Activation of the nuclear factor-B by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11, 463-475
27. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
28. Satoh, A., Gukovskaya, A. S., Nieto, J. M., Cheng, J. H., Gukovsky, I., Reeve, J. R. Jr., Shimosegawa, T., Pandol, S. J. (2004) PKC- and - regulate NF-B activation induced by cholecystokinin and TNF- pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G582-91
29. Enright, A. J., John, B., Gaul, U., Tuschl, T., Sander, C., and Marks, D. S. (2003) MicroRNA targets in Drosophila. Genome Biol. 5, R1
30. Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., and Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (Pubitemid 40617277)
31. Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S. K., Aure, M. R., Russnes, H. G., Rønneberg, J. A., Johnsen, H., Navon, R., Rødland, E., Mäkelä, R., Naume, B., Perälä, M., Kallioniemi, O., Kristensen, V. N., Yakhini, Z., and Børresen-Dale, A. L. (2011) miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PloS One 6, e16915
32. Liu, C. J., Tsai, M. M., Hung, P. S., Kao, S. Y., Liu, T. Y., Wu, K. J., Chiou, S. H., Lin, S. C., and Chang, K. W. (2010) miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res. 70, 1635-1644
33. Lynam-Lennon, N., Reynolds, J. V., Marignol, L., Sheils, O. M., Pidgeon, G. P., and Maher, S. G. (2012) MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J. Mol. Med. 90, 1449-1458
34. Wang, C. J., Stratmann, J., Zhou, Z. G., and Sun, X. F. (2010) Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 10, 616
35. Liu, X., Cheng, Y., Chen, X., Yang, J., Xu, L., and Zhang, C. (2011) MicroRNA- 31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J. Biol. Chem. 286, 42371-42380
36. Augoff, K., Das, M., Bialkowska, K., McCue, B., Plow, E. F., and Sossey- Alaoui, K. (2011) miR-31 is a broad regulator of -1-integrin expression and function in cancer cells. Mol. Cancer Res. 9, 1500-1508
37. Sun, S. C. (2011) Non-canonical NF-B signaling pathway. Cell Res. 21, 71-85
38. Xu, H., Liu, P., Liang, L., Danesh, F. R., Yang, X., Ye, Y., Zhan, Z., Yu, X., Peng, H., and Sun, L. (2006) RhoA-mediated, tumor necrosis factor -induced activation of NF-B in rheumatoid synoviocytes: inhibitory effect of simvastatin. Arthritis Rheum. 54, 3441-3451
39. Yang, W., Xia, Y., Cao, Y., Zheng, Y., Bu, W., Zhang, L., You, M. J., Koh, M. Y., Cote, G., Aldape, K., Li, Y., Verma, I. M., Chiao, P. J., Lu, Z. (2012) EGFR-Induced and PKC- Monoubiquitylation-Dependent NF-B Activation Upregulates PKM2 Expression and Promotes Tumorigenesis. Mol. Cell 48, 711-784